Rebecca Goulding

Title: Research Fellow (2010)

Rebecca GouldingRebecca Goulding joined Sauder S3i in 2009 and is currently working on the Health Technology Access Policy Project. Her research focusses on the potential of alternative intellectual property strategies (e.g. open innovation patent pools, public domain) to promote neglected disease drug discovery and development.  Rebecca completed her BSc in genetics and MSc in hematology/oncology at the University of Dublin, Trinity College.  She continued her graduate studies at the BC Cancer Research Centre, finishing her PhD in genetics at University of British Columbia in 2008. During the last years of her PhD, Rebecca became involved with a student group called Universities Allied for Essential Medicines (UAEM), which inspired her interest in global health research, particularly in the area of neglected disease drug research.